La cadena de opciones muestra datos clave de las opciones de acciones de Pennant Gr a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Pennant Gr..

Pennant Gr (NASDAQ:PNTG) Bolsa, Cadena de Opciones

PENNANT GROUP INC/THE

Pennant Gr

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Pennant Group

Pennant Group Inc

B of A Securities analyst Anna Lizzul maintains Kenvue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) with a Buy and lowers the price target from $27 to $25.

News

Price Target

Analyst Ratings

KVUE

B of A Securities Maintains Buy on Kenvue, Lowers Price Target to $25

Jamf (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>), the standard in managing and securing Apple at work, today announced a strategic reinvestment plan to help drive long-term growth, improve operational efficiency and enhance shareholder value.
Jamf's recent comprehensive systems update, spanning both front- and back-office operations, has provided enhanced insights into Jamf's business and growth opportunities. As a result, Jamf is embarking on a strategic reinvestment plan to support the continued success of the business. This plan includes strategic reallocation of resources to allow for investment in areas with the highest potential to fuel growth and drive additional operational leverage in the business. Two key focus areas are:
1. Go-To-Market Enhancement
Jamf is taking steps to realign its go-to-market organization to allow for investment in areas that have the greatest opportunity for growth and align with our platform strategy via the Jamf for Mac, Jamf for Mobile, Jamf for K-12, and Jamf for SMB solutions.
<ul>
<li>Enhance growth in Enterprise: increasing investment and resources to support Enterprise customers, which deliver higher growth, stronger retention, and greater return on investment.&nbsp;</li>
<li>Simplify approach to SMB: scaling through the channel while also developing a more automated customer solution and experience to deliver greater customer value and improve operational efficiency.</li>
</ul>
2. AI Investments
In addition to the efficiencies experienced over the last year from deploying AI within the sales, product and customer success groups, Jamf is further accelerating investments in AI capabilities that improve the customer experience in the Jamf product platform and drive further productivity enhancements by accelerating delivery of AI- and automation-driven solutions across the entire organization.
In order to facilitate the strategic reinvestment plan, the Company will reduce its workforce by approximately 6.4%. The Company will reduce roles across its go-to-market and other functions to align with the strategic reinvestment plan, as well as reducing spans and layers throughout the organization.
Jamf currently estimates that it will incur charges of approximately $11.0 to $12.5 million in connection with the workforce reduction, consisting of cash expenditures for notice period and severance payments, employee benefits, and related costs. The Company expects that most of the charges will be incurred in the third quarter of 2025 and that the execution of the Plan will be substantially complete by the end of the fourth quarter of 2025. The Company intends to exclude the charges associated with the workforce reduction from certain of its non-GAAP financial measures.&nbsp;

Management

JAMF

Jamf Launches Strategic Reinvestment Plan With AI Focus, Go-to-Market Realignment, And 6.4% Workforce Reduction; Expects $11M - $12.5M In Restructuring Charges

Contracts

OSS Announces Aggregate $3.9M In New Awards From US-Based Prime Defense Contractor

JMP Securities analyst Jordan Bender maintains Flutter Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>) with a Market Outperform and raises the price target from $301 to $323.

FLUT

JMP Securities Maintains Market Outperform on Flutter Entertainment, Raises Price Target to $323

CAPT

Captivision Regains Nasdaq Compliance On Market Value And Bid Price Requirements

Biotech

General

ALLR

Allarity Therapeutics Signs Licensing And Laboratory Services Agreement With An EU-Based Biotechnology Company To Supply Transcriptome Analysis Services

COOT

Australian Oilseeds Holdings Partners With SMART MARKETING For Sales, Marketing And Distrbiution Of GEO Brand In Vietnam.

Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension
This patent covers novel cyclic peptides and their use in treating solid tumors

Legal

LSTA

U.S. Patent And Trademark Office Issues Lisata Therapeutics Composition Of Matter Patent For Certepetide Through March 2040 With Opportunity For Patent Term Extension

Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, and its clinical development division Sardocor, together with the University of Kansas Medical Center, today announced the successful treatment of the first patient in the MUSIC-DMD Phase 1b clinical trial. The trial is investigating AAV1.SERCA2a, a one-time gene therapy treatment for cardiomyopathy secondary to Duchenne muscular dystrophy (DMD-CM).
The patient was successfully treated via left radial artery access using Medera's proprietary minimally invasive intracoronary infusion methodology. The patient tolerated the procedure well and was discharged following an overnight hospital stay for observation.
The MUSIC-DMD Phase 1b trial is an open-label, controlled study evaluating the safety and efficacy of AAV1.SERCA2a, an adeno-associated virus serotype 1 (AAV1) gene therapy that delivers the SERCA2a gene directly to heart muscle cells, in adult males with DMD-associated cardiomyopathy. The study will enroll up to 12 participants across low-dose, high-dose, and control groups. DMD-associated cardiomyopathy is characterized by calcium overload in heart muscle cells, leading to progressive fibrosis and heart failure. AAV1.SERCA2a aims to restore calcium handling in DMD-CM patients by increasing SERCA2a protein production, potentially reversing the underlying disease process.
 &nbsp;

KVAC

Medera And University Of Kansas Medical Center Announce Treatment Of First Patient In MUSIC-DMD Phase 1b Clinical Trial For Duchenne Muscular Dystrophy

B of A Securities analyst Noah Hungness upgrades National Fuel Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NFG#NYSE">NFG</a>) from Underperform to Buy and raises the price target from $85 to $107.

Upgrades

B of A Securities Upgrades National Fuel Gas to Buy, Raises Price Target to $107

<ul>
<li>Mainz Biomed launched eAArly DETECT 2, a US feasibility study to evaluate the Company's next generation colorectal cancer (CRC) test, integrating its proprietary mRNA biomarkers, AI developed algorithm and FIT test, over a population of approximately 2,000 patients, all of average risk, to validate the leading results of previous feasibility studies, which included average risk and identified risk patients.</li>
<li>The Company entered into a strategic partnership with labor team w ag, a renowned diagnostic laboratory based in Goldach, Switzerland. This collaboration introduces ColoAlert&#xAE;, a DNA-based colorectal cancer screening test to the Swiss market for the very first time, marking Mainz Biomed's initial footprint in Switzerland.</li>
<li>Mainz Biomed entered into a technology partnership with UK-based EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalized treatments for cancer, cardiovascular and infectious diseases. Under the agreement, EDX Medical will access the Company's molecular diagnostic technology as part of the expansion of its portfolio of products for sale in the UK.</li>
<li>Mainz Biomed entered into a License and Option Agreement with Liquid Biosciences ("Liquid") to access a portfolio of novel mRNA biomarkers for the non-invasive detection of pancreatic cancer with a blood test.&nbsp;The parties, under the Agreement, plan to develop this blood-based test for potential future FDA applications. The discovery process included multiple independent pancreatic cancer study cohorts. Liquid used their proprietary EMERGE platform to identify a panel of clinically relevant mRNA biomarkers from a blood-based cohort of 285 subjects with 35 pancreatic cancer patients. In the analysis, the biomarkers coupled with the proprietary algorithm developed by Liquid achieved overall sensitivity of 95% and a 98% specificity for the detection of pancreatic cancer. If the statistical results are replicable after the integration into a new product, it has the potential to ultimately position Mainz Biomed's test to be the most robust and accurate screening test for pancreatic cancer on the market.</li>
<li>The Company announced the commencement of the next phase in its PancAlert project, a research initiative focused on developing a non-invasive blood-based screening test for the early detection of pancreatic cancer. The feasibility phase is intended to confirm the discovery analysis performed in early 2025 in partnership with Liquid Biosciences which demonstrated sensitivity of 95% with specificity of 98% for the detection of pancreatic cancer in blood samples.</li>
<li>Mainz Biomed announced that its pancreatic cancer project will receive public funding from the Investitions- und Strukturbank Rheinland-Pfalz (ISB), the development bank of the German federal state of Rheinland-Pfalz. Under the ISB's Innovation and Technology Support Program (Innovations- und Technologieförderungsprogramm), the state will fund up to 50% of the project's total costs. This direct governmental support represents a strong endorsement of the scientific and societal value of the Company's non-invasive, blood-based screening test for the early detection of pancreatic cancer and will accelerate its development.</li>
<li>The Company received formal notice from The Nasdaq Stock Market LLC ("Nasdaq") confirming that it has regained compliance with the minimum stockholders' equity requirement for continued listing on the Nasdaq Capital Market set forth in Listing Rule 5550(b)(1). Mainz Biomed had previously received confirmation that it had regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The Company is now in full compliance with all Nasdaq continued listing requirements and will continue to be listed and traded on The Nasdaq Capital Market.</li>
<li>Mainz Biomed priced a follow-on offering of 2,000,000 units, with each unit consisting of one ordinary share (or pre-funded warrant in lieu thereof), one Series A warrant (five-year life) to purchase one ordinary share, and one Series B warrant (one-year life) to purchase one ordinary share for gross proceeds of approximately $4.0 million. Each unit was sold at an effective offering price of $2.00 per unit.</li>
</ul>

MYNZ

Mainz Biomed Reviews H1 2025 Accomplishments; Plans To Complete eAArly DETECT 2 Feasibility Study In H2 2025.

HOVR

HOVRW

New Horizon Aircraft And ZeroAvia Plan To Work Together On Developing Regional Hydrogen-Electric VTOL Air Travel

OFAL

OFA Group Enters Committed Equity Purchase Agreement With Atsion Opportunity Fund LLC – Series 1 For Up To $100M, With Option To Expand To $200M Upon Mutual Agreement

<h3>Gainers</h3>
<ul>
<li>INNEOVA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INEO#NASDAQ">INEO</a>) shares moved upwards by 10.2% to $1.3 during Tuesday's pre-market session. The company's market cap stands at $11.6 million. </li>
<li>Jianzhi Education Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZ#NASDAQ">JZ</a>) stock rose 9.93% to $1.77. The market value of their outstanding shares is at $1.2 million. </li>
<li>Red Robin Gourmet Burgers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) shares moved upwards by 9.58% to $6.17. The market value of their outstanding shares is at $99.8 million. </li>
<li>Rent the Runway (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RENT#NASDAQ">RENT</a>) stock increased by 9.21% to $5.45. The market value of their outstanding shares is at $20.0 million. </li>
<li>TCTM Kids IT Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSA#NASDAQ">VSA</a>) shares rose 7.69% to $1.54. The company's market cap stands at $14.2 million. </li>
<li>Aureus Greenway Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGH#NASDAQ">AGH</a>) stock increased by 7.43% to $0.65. The company's market cap stands at $8.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Kaival Brands Innovations (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAVL#NASDAQ">KAVL</a>) stock fell 20.4% to $0.54 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.8 million. </li>
<li>Lobo EV Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOBO#NASDAQ">LOBO</a>) stock fell 10.66% to $0.55. The market value of their outstanding shares is at $5.2 million. </li>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) shares fell 10.0% to $1.71. The company's market cap stands at $64.1 million. </li>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock fell 7.81% to $0.65. The company's market cap stands at $14.1 million. </li>
<li>Autozi Internet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZI#NASDAQ">AZI</a>) stock declined by 6.4% to $0.25. The company's market cap stands at $30.4 million. </li>
<li>Revolve Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) stock decreased by 5.05% to $20.33. The market value of their outstanding shares is at $1.5 billion. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

FTEL

INEO

KAVL

LOBO

RENT

RRGB

RVLV

RYET

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Longevity Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) stock rose 127.6% to $6.02 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.6 million. </li>
<li>Cyclacel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) stock moved upwards by 44.46% to $4.78. The market value of their outstanding shares is at $5.2 million. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) stock rose 40.11% to $0.96. The market value of their outstanding shares is at $11.5 million. </li>
<li>OKYO Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKYO#NASDAQ">OKYO</a>) stock increased by 20.15% to $3.1. The market value of their outstanding shares is at $96.5 million. </li>
<li>Cadrenal Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVKD#NASDAQ">CVKD</a>) shares rose 19.43% to $14.93. The market value of their outstanding shares is at $24.5 million. </li>
<li>60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) shares rose 16.85% to $2.53. The company's market cap stands at $3.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Organogenesis Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGO#NASDAQ">ORGO</a>) stock declined by 24.3% to $3.4 during Tuesday's pre-market session. The company's market cap stands at $569.5 million. </li>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) shares declined by 18.05% to $7.9. The company's market cap stands at $30.5 million. </li>
<li>Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) stock decreased by 17.53% to $0.58. The market value of their outstanding shares is at $27.4 million. </li>
<li>Burning Rock Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNR#NASDAQ">BNR</a>) stock decreased by 17.5% to $3.82. The company's market cap stands at $47.4 million. </li>
<li>Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) shares decreased by 15.6% to $0.4. The market value of their outstanding shares is at $9.7 million. </li>
<li>MiNK Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INKT#NASDAQ">INKT</a>) shares fell 13.82% to $35.0. The market value of their outstanding shares is at $161.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CVKD

CYCC

INKT

KAPA

OKYO

ORGO

RANI

SONN

SXTP

TLPH

Longevity Health Holdings, Inc. - Common Stock

XAGE

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Li Bang International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBGJ#NASDAQ">LBGJ</a>) stock increased by 9.7% to $1.55 during Tuesday's pre-market session. The company's market cap stands at $26.4 million. </li>
<li>Graphjet Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) shares increased by 8.81% to $0.08. The market value of their outstanding shares is at $10.3 million. </li>
<li>TPI Composites (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) shares increased by 8.19% to $0.84. The company's market cap stands at $37.8 million. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) stock moved upwards by 6.95% to $3.03. The market value of their outstanding shares is at $98.8 million. </li>
<li>Custom Truck One Source (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTOS#NYSE">CTOS</a>) shares rose 6.79% to $5.5. The market value of their outstanding shares is at $1.1 billion. </li>
<li>Virco Mfg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRC#NASDAQ">VIRC</a>) stock increased by 6.74% to $8.7. The market value of their outstanding shares is at $128.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>OFA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFAL#NASDAQ">OFAL</a>) shares decreased by 23.2% to $2.55 during Tuesday's pre-market session. The company's market cap stands at $46.2 million. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) stock declined by 18.62% to $1.53. The market value of their outstanding shares is at $14.1 million. </li>
<li>Stardust Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) shares decreased by 14.38% to $0.41. The company's market cap stands at $39.0 million. </li>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) stock declined by 7.44% to $0.38. The company's market cap stands at $13.1 million. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) stock decreased by 7.01% to $0.95. The company's market cap stands at $4.2 million. </li>
<li>Energous (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WATT#NASDAQ">WATT</a>) stock fell 6.35% to $0.4. The company's market cap stands at $14.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIK

CTOS

LBGJ

MCRP

SDST

SGLY

TPIC

VIRC

WATT

12 Industrials Stocks Moving In Tuesday's Pre-Market Session

JMP Securities analyst Jordan Bender maintains Sportradar Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRAD#NASDAQ">SRAD</a>) with a Market Outperform and raises the price target from $25 to $30.

SRAD

JMP Securities Maintains Market Outperform on Sportradar Gr, Raises Price Target to $30

<h3>Gainers</h3>
<ul>
<li>SMX (Security Matters) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMX#NASDAQ">SMX</a>) stock moved upwards by 62.5% to $2.73 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.4 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock increased by 18.19% to $0.65. The market value of their outstanding shares is at $3.8 million. </li>
<li>Kingsoft Cloud Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) shares increased by 17.07% to $14.88. The company's market cap stands at $3.4 billion. </li>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) shares moved upwards by 16.13% to $1.23. The company's market cap stands at $27.3 million. </li>
<li>VNET Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNET#NASDAQ">VNET</a>) shares increased by 14.89% to $9.1. The company's market cap stands at $2.1 billion. </li>
<li>GDS Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) stock increased by 13.42% to $39.7. The market value of their outstanding shares is at $6.7 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TROOPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROO#NASDAQ">TROO</a>) shares declined by 30.6% to $0.93 during Tuesday's pre-market session. The company's market cap stands at $136.1 million. </li>
<li>Argo Blockchain plc - 8.75% Senior Notes due 2026 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBKL#NASDAQ">ARBKL</a>) stock declined by 13.64% to $3.8. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock fell 8.99% to $3.95. The company's market cap stands at $6.5 million. </li>
<li>Datavault AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DVLT#NASDAQ">DVLT</a>) shares decreased by 8.45% to $0.63. The market value of their outstanding shares is at $45.3 million. </li>
<li>Sequans Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQNS#NYSE">SQNS</a>) stock declined by 7.61% to $4.98. The market value of their outstanding shares is at $769.2 million. </li>
<li>Abits Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) shares declined by 7.5% to $5.0. The company's market cap stands at $12.8 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABTS

Argo Blockchain plc - 8.75% Senior Notes due 2026

ARBKL

DVLT

MOVE

SOBR

SQNS

TROO

VNET

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

B of A Securities analyst Justin Post maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Buy and raises the price target from $765 to $775.

B of A Securities Maintains Buy on Meta Platforms, Raises Price Target to $775

ZenaTech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) (FSE: 49Q) (BMV:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#BMV">ZENA</a>) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces it will accelerate expansion of its Phoenix Arizona-based facilities -- including tripling the square footage size -- to enable full US drone manufacturing, assembly and testing. This expansion comes earlier than expected due to the recent transformative US policy directives from the White House, the Department of Defense, and the recently passed ‘One Big Beautiful Bill' that collectively have unlocked federal funding for domestic production, cut outdated certification and procurement barriers, and fast-tracked deployment directly to frontline units without requiring Blue or Green UAS (Unmanned Aerial System) certification.
These new directives make it dramatically easier and faster for American drone companies—especially those building Group 1 and 2 affordable drone systems—to sell directly to the military, scale production, and innovate without delays from traditional defense procurement bottlenecks. Together, they signal a clear national priority: build drones in America, field them fast, and outpace adversaries.

BMV:ZENA

ZENA

ZenaTech To Accelerate Expansion Of Phoenix Arizona-Based Facilities To Enable Full US Drone Manufacturing, Assembly And Testing

Press Releases

Pennant Acquires Senior Living Communities in Idaho and Texas

Pennant Announces Fourth Quarter and Full Year 2024 Earnings Release and Call

Earnings

Pennant Reports Fourth Quarter and Fiscal Year 2024 Results

Pennant Group to Participate in the 2025 Oppenheimer Annual Healthcare Conference

Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona

Pennant Announces First Quarter 2025 Earnings Release and Call

Pennant Reports First Quarter 2025 Results

The Pennant Group Appoints Suzanne Snapper as Director

CareTrust REIT Positions for Continued Growth with New $500 Million Term Loan and New Hires

Pennant Announces Home Health Acquisition in Southern California

CTRE

ENSG

PNTG

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

Amedisys

AMN Healthcare Services

Astrana Health

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Comments

Pennant Gr

Pennant Gr (PNTG) Opciones

Pennant Gr (NASDAQ:PNTG) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL